PRICOLO, PAOLA
PRICOLO, PAOLA
Universita' degli Studi di MILANO
Is whole-body magnetic resonance imaging a source of anxiety in oncological patients?
2023 K. Mazzocco, D. Busacchio, P.E. Summers, C. Marzorati, P. Pricolo, G. Petralia, G. Pravettoni
Psychological characteristics and satisfaction for the whole-body MRI in cancer screening
2023 D. Busacchio, D. Mazzoni, K. Mazzocco, P. Pricolo, P.E. Summers, G. Petralia, G. Pravettoni
High-performance prediction models for prostate cancer radiomics
2023 L.J. Isaksson, M. Repetto, P.E. Summers, M. Pepa, M. Zaffaroni, M.G. Vincini, G. Corrao, G.C. Mazzola, M. Rotondi, F. Bellerba, S. Raimondi, Z. Haron, S. Alessi, P. Pricolo, F.A. Mistretta, S. Luzzago, F. Cattani, G. Musi, O. De Cobelli, M. Cremonesi, R. Orecchia, D. La Torre, G. Marvaso, G. Petralia, B.A. Jereczek-Fossa
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion : a plan comparison
2022 R. Cambria, D. Ciardo, A. Bazani, F. Pansini, E. Rondi, D. Maestri, D. Zerini, G. Marvaso, P. Romanelli, G. Timon, C. Fodor, G. Petralia, S. Alessi, P. Pricolo, B. Vischioni, P. Fossati, S. Molinelli, S. Russo, M. Ciocca, O. De Cobelli, G. Renne, R. Orecchia, F. Cattani, B.A. Jereczek-Fossa
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis
2022 G. Corrao, G. Marvaso, M. Zaffaroni, S. Volpe, M. Augugliaro, C.I. Fodor, D. Zerini, A. Vingiani, F.A. Mistretta, S. Luzzago, S. Alessi, P. Pricolo, G. Musi, O. De Cobelli, G. Renne, M. Manzoni, G. Petralia, R. Orecchia, B.A. Jereczek-Fossa
Whole-body magnetic resonance imaging: Technique, guidelines and key applications
2021 P. Summers, G. Saia, A. Colombo, P. Pricolo, F. Zugni, S. Alessi, G. Marvaso, B.A. Jereczek-Fossa, M. Bellomi, G. Petralia
Value Attribution in the Decision to Use of Whole Body MRI for Early Cancer Diagnosis
2021 D. Busacchio, K. Mazzocco, D. Radice, P.E. Summers, P. Pricolo, G. Pravettoni, G. Petralia
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)
2021 S.G. Gugliandolo, M. Pepa, L.J. Isaksson, G. Marvaso, S. Raimondi, F. Botta, S. Gandini, D. Ciardo, S. Volpe, G. Riva, D.P. Rojas, D. Zerini, P. Pricolo, S. Alessi, G. Petralia, P.E. Summers, F.A. Mistretta, S. Luzzago, F. Cattani, O. De Cobelli, E. Cassano, M. Cremonesi, M. Bellomi, R. Orecchia, B.A. Jereczek-Fossa
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy
2021 S. Alessi, R. Maggioni, S. Luzzago, A. Colombo, P. Pricolo, P.E. Summers, G. Saia, M. Manzoni, G. Renne, G. Marvaso, O. De Cobelli, M. Bellomi, B.A. Jereczek-Fossa, G. Petralia
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates
2021 S. Luzzago, M. Luca Piccinelli, F.A. Mistretta, R. Bianchi, G. Cozzi, E. di Trapani, A. Cioffi, M. Catellani, M. Fontana, L.M.I. Jannello, F.M.G. Botticelli, G. Marvaso, S. Alessi, P. Pricolo, M. Ferro, D. Matei, B.A. Jereczek-Fossa, N. Fusco, G. Petralia, O. de Cobelli, G. Musi
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis
2021 G. Corrao, G. Marvaso, M. Zaffaroni, C.I. Fodor, S. Volpe, L. Bergamaschi, D. Zerini, A. Vingiani, G. Petralia, S. Alessi, P. Pricolo, G. Renne, R. Orecchia, B.A. Jereczek-Fossa
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) : inter-observer agreement between readers of different expertise levels
2020 P. Pricolo, E. Ancona, P. Summers, J. Abreu-Gomez, S. Alessi, B.A. Jereczek-Fossa, O. De Cobelli, F. Nole, G. Renne, M. Bellomi, A.R. Padhani, G. Petralia
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort
2020 S. Luzzago, O. de Cobelli, F.A. Mistretta, M.L. Piccinelli, V. Lorusso, M. Morelli, R. Bianchi, M. Catellani, G. Cozzi, E. Di Trapani, P. Pricolo, S. Alessi, M. Ferro, G. Marvaso, D.-. Matei, B.A. Jereczek-Fossa, G. Petralia, G. Musi
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3)
2020 S. Luzzago, M. Catellani, E. Di Trapani, G. Cozzi, F.A. Mistretta, R. Bianchi, P. Pricolo, A. Conti, E. Ancona, N. Piacentini, S. Alessi, G. Renne, M. Ferro, D.-. Matei, G. Musi, B.A. Jereczek-Fossa, G. Petralia, O. de Cobelli
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218)
2020 G. Marvaso, S.G. Gugliandolo, F. Bellerba, S. Gandini, G. Corrao, S. Volpe, D.P. Rojas, G. Riva, D. Zerini, M. Pepa, C.I. Fodor, E. La Rocca, P. Pricolo, S. Alessi, G. Petralia, F.A. Mistretta, R. Cambria, F. Cattani, O. De Cobelli, R. Orecchia, B.A. Jereczek-Fossa
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling
2020 S. Luzzago, G. Petralia, D. Maresca, I. Sabatini, G. Cordima, A. Brescia, F. Verweij, G. Garelli, F.A. Mistretta, A. Cioffi, P. Pricolo, S. Alessi, M. Ferro, D.-. Matei, G. Renne, O. de Cobelli, G. Musi
Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents
2020 P. Tarantino, A. Marra, S. Gandini, M. Minotti, P. Pricolo, G. Signorelli, C. Criscitiello, M. Locatelli, C. Belli, M. Bellomi, G. Curigliano
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients
2019 S. Alessi, P. Pricolo, P. Summers, M. Femia, E. Tagliabue, G. Renne, R. Bianchi, G. Musi, O. De Cobelli, B.A. Jereczek-Fossa, M. Bellomi, G. Petralia
Whole-body magnetic resonance imaging (WB-MRI) in oncology : recommendations and key uses
2019 G. Petralia, A.R. Padhani, P. Pricolo, F. Zugni, M. Martinetti, P.E. Summers, L. Grazioli, S. Colagrande, A. Giovagnoni, M. Bellomi
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer
2018 F. Zugni, F. Ruju, P. Pricolo, S. Alessi, M. Iorfida, M.A. Colleoni, M. Bellomi, G. Petralia